AKIN GUMP STRAUSS HAUER & FELD

Lobbying for AMGEN USA, INC. · Biotechnology healthcare products.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Taxation/Internal Revenue Code

Analysis and advice on international tax issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.